These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 36880313

  • 21. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation.
    Hamadeh F, Awadallah A, Meyerson HJ, Beck RC.
    Cytometry B Clin Cytom; 2020 Jan; 98(1):43-51. PubMed ID: 30614203
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
    Sang W, Wang CF, Cheng YF, Liu X, Li XX, Gulinar A, Li JZ, Zhang W.
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):326-30. PubMed ID: 22883672
    [Abstract] [Full Text] [Related]

  • 26. Blastic plasmacytoid dendritic cell neoplasm: emerging developments and special considerations for 2023.
    Pemmaraju N, Kantarjian H.
    Clin Adv Hematol Oncol; 2023 May; 21(5):257-264. PubMed ID: 37145496
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison and Development of Immunohistochemical Diagnostic Criteria for Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Sakamoto K, Baba S, Okumura Y, Momose S, Ono S, Tonooka A, Ichinohasama R, Takakuwa E, Nakasone H, Ohshima K, Takeuchi K.
    Mod Pathol; 2023 Oct; 36(10):100253. PubMed ID: 37380058
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Plasmacytoid dendritic cell neoplasms.
    Lee YJ, Kim Y, Park SH, Jo JC.
    Blood Res; 2023 Apr 30; 58(S1):90-95. PubMed ID: 37105563
    [Abstract] [Full Text] [Related]

  • 31. Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Pemmaraju N, Deconinck E, Mehta P, Walker I, Herling M, Garnache-Ottou F, Gabarin N, Campbell CJV, Duell J, Moshe Y, Mughal T, Mohty M, Angelucci E.
    Clin Lymphoma Myeloma Leuk; 2024 Apr 30; 24(4):e130-e137. PubMed ID: 38267355
    [Abstract] [Full Text] [Related]

  • 32. A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body.
    Cui XB, Jin J, Pang XL, Li S, Liu CX, Li TT, Peng H, Zhang SM, Li L, Liang WH, Chen YZ, Li F.
    Int J Clin Exp Pathol; 2014 Apr 30; 7(7):4391-9. PubMed ID: 25120824
    [Abstract] [Full Text] [Related]

  • 33. Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm.
    Lee SS, McCue D, Pemmaraju N.
    Expert Rev Anticancer Ther; 2020 Jul 30; 20(7):543-550. PubMed ID: 32460559
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123.
    Zanotta S, Galati D, De Filippi R, Pinto A.
    Int J Mol Sci; 2024 Jan 25; 25(3):. PubMed ID: 38338733
    [Abstract] [Full Text] [Related]

  • 36. Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN).
    Wilson NR, Pemmaraju N.
    Expert Opin Pharmacother; 2022 Mar 25; 23(4):431-438. PubMed ID: 35060807
    [Abstract] [Full Text] [Related]

  • 37. TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.
    Alayed K, Patel KP, Konoplev S, Singh RR, Routbort MJ, Reddy N, Pemmaraju N, Zhang L, Shaikh AA, Aladily TN, Jain N, Luthra R, Medeiros LJ, Khoury JD.
    Am J Hematol; 2013 Dec 25; 88(12):1055-61. PubMed ID: 23940084
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Xue T, Budde LE.
    Hematol Oncol Clin North Am; 2020 Jun 25; 34(3):575-587. PubMed ID: 32336421
    [Abstract] [Full Text] [Related]

  • 40. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm.
    He J, Garcia MB, Connors JS, Nuñez CA, Quesada AE, Gibson A, Roth M, Cuglievan B, Pemmaraju N, McCall D.
    J Pediatr Hematol Oncol; 2023 Nov 01; 45(8):e1001-e1004. PubMed ID: 37661300
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.